ZYDUSLIFE - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 3.8
| Stock Code | ZYDUSLIFE | Market Cap | 91,059 Cr. | Current Price | 905 ₹ | High / Low | 1,059 ₹ |
| Stock P/E | 18.9 | Book Value | 215 ₹ | Dividend Yield | 1.22 % | ROCE | 30.6 % |
| ROE | 31.2 % | Face Value | 1.00 ₹ | DMA 50 | 911 ₹ | DMA 200 | 945 ₹ |
| Chg in FII Hold | -0.28 % | Chg in DII Hold | 0.22 % | PAT Qtr | 1,157 Cr. | PAT Prev Qtr | 385 Cr. |
| RSI | 53.8 | MACD | -5.36 | Volume | 5,22,626 | Avg Vol 1Wk | 5,56,706 |
| Low price | 795 ₹ | High price | 1,059 ₹ | PEG Ratio | 0.26 | Debt to equity | 0.35 |
| 52w Index | 41.7 % | Qtr Profit Var | 46.4 % | EPS | 48.0 ₹ | Industry PE | 29.1 |
📊 Analysis: ZYDUSLIFE shows moderate potential for intraday trading. Current price (905 ₹) is slightly below the 50 DMA (911 ₹) and well below the 200 DMA (945 ₹), indicating short-term weakness. RSI at 53.8 suggests neutral momentum, while MACD (-5.36) reflects mild bearishness. Volume is slightly below average, hinting at limited intraday volatility.
💰 Optimal Buy Price: Around 900–905 ₹ (near current support zone).
📈 Profit-Taking Levels: 920–930 ₹ (short-term resistance).
⚠️ Stop-Loss: 890 ₹ (to protect against downside risk).
⏱️ If Already Holding: Consider exiting if price fails to sustain above 905 ₹ with weak momentum, or book profits near 920–930 ₹ if volume spikes positively. Watch intraday RSI crossing 60 for bullish confirmation, or a drop below 50 for bearish exit signals.
Positive
- Strong ROCE (30.6%) and ROE (31.2%) indicate efficient capital use.
- Quarterly PAT surged to 1,157 Cr. from 385 Cr., showing robust earnings growth.
- Low PEG ratio (0.26) suggests undervaluation relative to growth.
- EPS of 48 ₹ supports healthy profitability.
Limitation
- MACD is negative, showing weak short-term momentum.
- Price below 200 DMA indicates medium-term bearish trend.
- Volume slightly below weekly average, limiting intraday volatility.
Company Negative News
- Decline in FII holdings (-0.28%) reflects reduced foreign investor confidence.
Company Positive News
- DII holdings increased (+0.22%), showing domestic institutional support.
- Strong quarterly profit growth (+46.4%) boosts investor sentiment.
Industry
- Industry PE at 29.1 is higher than company PE (18.9), suggesting ZYDUSLIFE is undervalued compared to peers.
- Pharma sector remains defensive with steady demand outlook.
Conclusion
⚖️ ZYDUSLIFE is a moderately good candidate for intraday trading today. While fundamentals are strong, technical indicators show mixed signals. Traders may attempt quick entries near 900–905 ₹ with profit targets around 920–930 ₹, but should maintain strict stop-loss discipline at 890 ₹ due to weak momentum.